Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation.
Yamanaka S, Furihata H, Yanagihara Y, Taya A, Nagasaka T, Usui M, Nagaoka K, Shoya Y, Nishino K, Yoshida S, Kosako H, Tanokura M, Miyakawa T, Imai Y, Shibata N, Sawasaki T.
Yamanaka S, et al. Among authors: kosako h.
Nat Commun. 2023 Aug 18;14(1):4683. doi: 10.1038/s41467-023-40385-9.
Nat Commun. 2023.
PMID: 37596276
Free PMC article.